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Abstract 
Background: In recent times, studies have demonstrated that carbon nanotubes are good candidates for use as 
vehicles for transfection of exogenous material into the cells. However, there are few studies evaluating the behavior 
of carbon nanotubes as DNA vectors and few of these studies have used multi-walled carbon nanotubes (MWCNTs) 
or carboxylated MWCNTs. Thus, this study aims to assess the MWCNTs’ (carboxylated or not) efficiency in the increase 
in expression of the tetravalent vaccine candidate (TVC) plasmid vector for dengue virus in vitro using Vero cells, and 
in vivo, through the intramuscular route, to evaluate the immunological response profile.
Results: Multi-walled carbon nanotubes internalized by Vero cells, have been found in the cytoplasm and nucleus 
associated with the plasmid. However, it was not efficient to increase the messenger ribonucleic acid (mRNA) com-
pared to the pure vaccine candidate associated with Lipofectamine® 2000. The in vivo experiments showed that the 
use of intramuscular injection of the TVC in combination with MWCNTs reduced the immune response compared to 
pure TVC, in a general way, although an increase was observed in the population of the antibody-producing B cells, as 
compared to pure TVC.
Conclusions: The results confirm the data found by other authors, which demonstrate the ability of nanotubes to 
penetrate target cells and reach both the cytoplasm and the cell nucleus. The cytotoxicity values are also in accord-
ance with the literature, which range from 5 to 20 µg/mL. This has been found to be 10 µg/mL in this study. Although 
the expression levels are higher in cells that receive the pure TVC transfected using Lipofectamine® 2000, the nano-
tubes show an increase in B-cells producing antibodies.
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Background
In 2012 the World Health Organization (WHO) classified 
dengue as “the most important mosquito-borne disease 
in the world”, mainly because of the significant geograph-
ical distribution of the virus and the vector, including in 
areas that were previously unaffected by the disease; and 
also the subsequent costs brought on by dengue [1, 2]. In 
the same year a study conducted by Brady and colleagues 
suggested that a total of 3970 million people living world-
wide in 128 countries were at risk of contracting dengue. 
It has been estimated that the disease affects 824 million 
urban households and 763 million peri-urban homes [3].
There are four distinct dengue virus serotypes (DENV1-
4), all of which originate from the family Flaviviridae and 
genus Flavivirus. The fifth and latest proposed serotype 
of the dengue virus is DENV5, announced in October 
2013. DENV5 was detected during the screening of viral 
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samples taken from a patient admitted in a hospital in 
the Malaysian state of Sarawak in the year 2007. Genetic 
recombination, natural selection, and genetic bottlenecks 
have been implicated as factors that can lead to the emer-
gence of new serotypes [4].
The viral infection may be eventually asymptomatic, 
but may also result in disease, ranging from rapid undif-
ferentiated febrile episodes to severe life-threatening 
forms. The virulence is associated with a serotype and 
its genetic variations. Secondary infections are related to 
the occurrence of the most severe forms of the disease—
dengue hemorrhagic fever (DHF) and dengue shock 
syndrome (DSS)—however, DHF/DSS can also occur in 
primary infections [5].
In the most acute infection models, neutralizing and 
non-neutralizing antibodies are involved in viral control, 
elimination, and protection. However, a possible harm-
ful role of virus-specific antibodies has been described. 
It has been pointed out that they may be the cause of 
worsening of infection in in vitro assays. This occurs by 
a mechanism called antibody-dependent enhancement 
(ADE) that occurs when pre-existing antibodies present 
in the body from a first dengue infection bind to another 
infecting DENV particle during a subsequent infection. 
The primary infection antibodies might not neutral-
ize the virus. Instead, the virus-antibody complex binds 
to the Fcy receptor in the circulating monocytes. The 
antibodies help the virus to infect the monocytes more 
efficiently. The result is an overall increase in virus rep-
lication and increased risk of more severe dengue forms 
[6].
Treatment of dengue is symptomatic as no specific 
antiviral drugs are available, therefore, the WHO con-
siders the establishment of an effective vaccine against 
these viruses a priority. The ideal dengue vaccine must 
have low levels of side effects, providing lasting protec-
tion and be tetravalent to prevent the occurrence of ADE. 
As the regions where dengue occurs are underdeveloped, 
the vaccine must be economically viable and preferably 
be administered in a single dose [7]. Research groups 
throughout the world have been trying to develop a vac-
cine against dengue, using some classical methods, such 
as, viral attenuation until the recombinant antigens are 
expressed into the expression vectors [8–17].
Efforts to create a dengue vaccine by conventional 
techniques such as attenuation and virus inactivation 
were not efficient. For this, molecular biological methods 
have also been employed to search for new strategies to 
develop vaccines against dengue, ranging from the viral 
chimeras to the development of DNA vaccines [11, 12, 
18–21]. The latter consists of a recombinant plasmid 
optimized for expression in eukaryotic cells encoding for 
expression of the antigen of interest [22].
DNA nuclear import is a relatively inefficient process, 
mainly due to the presence of cytoplasmic nucleases 
that can degrade the DNA plasmid before it reaches 
the nucleus [23]. Therefore, the use of new methods to 
improve the DNA nuclear import process is necessary as 
a fundamental part of the advancement in the DNA vac-
cine research. The use of carbon nanotubes (CNT) for 
the introduction of exogenous DNA into cells is a great 
interest area today and is in an intense phase of expan-
sion. Studies must be carried out to better understand 
how to use them and the potential risks involved in its 
animals use. Determination of optimal conditions for 
transfection, cell internalization mechanisms, routes 
of inoculation into animals, the role of electrical charge 
density, as well as significance of the length and width of 
the CNTs in transfection efficiency, need to be elucidated 
with additional studies.
The CNTs are categorized into two main types: single-
walled carbon nanotubes (SWCNTs) and multi-walled 
carbon nanotubes (MWCNTs). Their lengths can vary 
from a few 100 nm to a few microns and their diameter 
varies between 0.4–2  nm and 2–100  nm for SWCNTs 
and MWCNTs, respectively [24]. They are composed 
exclusively of carbon atoms, which are arranged in a 
regular hexagonal pattern in the shape of benzene rings 
forming graphene sheets [25].
In recent years, studies on CNTs have demonstrated that 
there may be an efficient way of increasing the internali-
zation as also the expression of DNA sequences, such as, 
vector plasmid expression [26–29]. However, these stud-
ies are very recent and little is known about using CNTs 
and how to improve their efficiency. Further investigation 
needs to be done in this area that is booming today.
As there are few studies evaluating the CNTs behav-
ior, such as, DNA vector in Vero cells and in vivo by the 
intramuscular route and as none of these studies used 
MWCNTs, this study aimed to assess the efficiency 
of MWCNTs in the introduction of exogenous DNA 
in vitro and in vivo.
Results and discussion
Conjugation of DNA to the CNTs and ability of CNTs 
to reach the cellular interior
There is an increasing demand for delivery of biological 
materials into cells, as success in various therapies has 
been limited by the difficulty in making these materi-
als reach the cells’ interior. The current methods used to 
introduce pure DNA into cells, combine low efficiency 
with significant cellular toxicity [30].
For plasmid DNA conjugation with the CNTs, both 
were subjected to sonication together. Subsequently 
transmission electron microscopy (TEM) was performed 
in four different groups: pure MWCNT, MWCNT-DNA, 
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pure c-MWCNT and DNA-c-MWCNT (c-MWCNT 
indicates that the MWCNTs were carboxylated).
Transmission electron microscopy showed the func-
tionalization of CNTs with the plasmid DNA and that 
c-MWCNTs had the same affinity for DNA than the 
MWCNTs not carboxylated. TEM also showed that the 
DNA had preferably connected at the ends of the both 
nanotubes types, with a higher tendency to form large 
clumps (Fig. 1).
To verify if the CNTs were able to reach the cell inte-
rior, Vero cells were transfected with the MWCNTs and 
c-MWCNTs and were subsequently subjected to TEM 
to check for the presence of CNTs inside the cells. The 
results showed that the CNTs had entered the cells, and 
were located in the cytoplasm and nucleus. However, 
the cells transfected with c-MWCNTs had a greater ten-
dency to introduce CNTs within the nucleus (Fig. 2).
In recent times, studies have demonstrated that car-
bon nanotubes are good candidates for use as vehicles 
for transfection of exogenous material into cells, such as 
DNA and proteins, as they cross the cell membrane in a 
passive manner, without causing damage to the cell and 
they have low cytotoxicity levels. As seen in the studies of 
Bianco and Kostarelos, nanotubes have been internalized 
by Vero cells and are found in the cytoplasm and nucleus 
[29, 31]. It has been seen that there is an association of 
plasmid DNA with both carboxylated MWCNTs, and it 
is non-carboxylated. These results are highly encouraging, 
with the use of carbon nanotubes as DNA vectors.
Real‑time PCR of transfected cells
Cells transfected with carboxylated and not carboxylated 
MWCNTs, when used alone or combined with plasmid 
DNA, were analyzed, to see if the TVC conjunction with 
MWCNTs led the cells to produce RNA messengers of 
domain III of the E protein. For this, a real-time poly-
merase chain reaction (PCR) was carried out, using the 
primers for domain III of the E protein of DENV2. It 
showed that only cells transfected with TVC using Lipo-
fectamine® 2000 had a significant increase in the mRNA 
levels, while the TVC in conjunction with MWCNTs and 
c-MWCNTs had a smaller increase in mRNA compared 
to the control, which was represented by cells transfected 
with the empty pVAX plasmid (Fig. 3).
The only study that used Vero cells demonstrated that 
a high concentration of SWCNTs had significant tox-
icity in this cell type, whereas, a low concentration of 
SWCNTs retained their potential as carriers for drug 
delivery [32]. Our results indicated that a low concen-
tration of MWCNTs for introduction of exogenous 
Fig. 1 TEM of MWCNTs combined or not with plasmid DNA. TEM 
of MWCNT pure and combined with plasmid DNA. a MWCNT; b 
DNA-MWCNT; c c-MWCNT; d DNA- c-MWCNT. Scale bars in a indicate 
200 nm; in b, c 1 μm and in d 500 nm
Fig. 2 TEM of Vero cells transfected with MWCNTs. TEM of Vero cells 
transfected with MWCNTs (arrows) (a) and (b) c-MWCNT (c) and (d). a, 
b and c, d show that they are in the cytoplasm and core, respectively. 
Details highlighted in the upper box. The scale bar indicates 2 μm in 
a (1 μm) and C (1 μm); 1 μm in b (1 μm) and d (500 nm). Details are 
indicated between parentheses. N core, C cytoplasm, M mitochondria
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DNA into Vero cells was not efficient, suggesting a dif-
ferent behavior for SWCNTs, when compared their effi-
ciency to delivery.
Western blot
In this assay is possible to confirm the great capabil-
ity of MWCNT and the improved c-MWCNT, which 
shown densitometry values 10X higher when compared 
to the CVT alone and 63 e 48  % higher than the CVT 
transfected using as vehicle Lipofectamine® 2000 and 
MWCNT, respectively (Fig. 4). This finding is surprising, 
in real time PCR was found that TVC-LF had a higher 
expression, but western blot assay shown that some 
few mRNA was translate into protein. Some factors are 
related to this finding, such as: transcription rate deter-
mined by mRNA sequence; transcription rate modu-
lation, related to de elements involved with external 
elements (regulatory proteins and ncRNA, for exam-
ple); protein stability; protein translate rate and protein 
transport [33]. Cheng et  al. [34] observe that protein 
regulation system act as a commutation, when mRNA 
expression increase, this will be counterbalanced by 
translate protein regulation steps, to achieve a steady 
state. Theoretical studies demonstrate the stabilization of 
proteins in the presence of multiwalled nanotubes [35], 
particularly due to the electrostatic or hydrophobic inter-
actions of certain protein regions and multiwalled carbon 
nanotubes.
Fig. 3 RT-PCR of Vero cells transfected and MTT assay. a RT-PCR of Vero cells transfected with the empty pVAX plasmid, only TVC, MWCNT function-
alized with TVC, and c-MWCNT functionalized with TVC. b, c MTT assay in Vero cells treated with c-MWCNTs pure preparations (c-MWCNT) (b) or 
functionalized with plasmid DNA (TVC-c-MWCNT) (c) to evaluate the cytotoxicity of preparations
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Cell viability assay with tetrazolium salt
Before proceeding with studies in mice, we first made a 
cell viability MTT assay, to determine which concentra-
tion of CNT generated a cytotoxic effect in Vero cells. 
For this, the cells were incubated with four different 
preparations (MWCNT, DNA-MWCNT, c-MWCNT, 
and DNA-c-MWCNT) in increasing concentrations of 
CNTs (from 1 to 200 µg/mL). The data obtained from the 
c-MWCNTs were used as the basis for a choice of 10 µg/
mL as the concentration used in further studies, as also 
the chosen concentration for the in  vivo assay (Fig.  5b, 
c). The concentration was consistent with other studies, 
which showed that the CNT concentrations between 5 
and 20 mg/mL had no cytotoxicity when tested in a cell 
culture [36, 37]. Adding DNA had little or no impact in 
the net toxicity of CNTs.
Immunophenotyping, lymphoproliferation, and cytokine 
detection
In the final part of the study, tests were done to deter-
mine the immune response profile generated in mice 
subjected to four different treatments (empty plasmid-
pVAX, tetravalent vaccine candidate-TVC, c-MWCNT, 
and TVC-c-MWCNT carboxylated). In the immu-
nophenotyping assay, the number of B, CD4+, CD8+, 
and CD62Llow cells for individual animals of each treat-
ment group was measured. When the TVC or TVC-c-
MWCNT groups were compared with the pVAX group, 
only the B cells showed a statistically relevant increase in 
cell count (Fig. 6). A slight, but not statistically significant 
increase could be observed in the CD8+ cell count in the 
c-MWCNT group. In the lymphoproliferation assay it 
was not possible to observe a significant increase of lym-
phocytes among the groups of animals treated with TVC, 
c-MWCNT, TVC-c-MWCNT, and the pVAX group, 
under different stimuli, but the difference was very strong 
as compared to that found when TVC-c-MWNTC was 
compared with TVC or f-MWNTC (Fig. 6a). The increase 
in the production of B cells in animals treated with TVC 
or conjugated TVC-c-MWCNTs was an important find-
ing, once it indicated an increase in antibody-producing 
cells in these animals—a desired characteristic to use as a 
future vaccine.
The production of cytokines by lymphocytes from ani-
mals when stimulated with the four serotypes of virus, in 
the four different treatments (pVAX, TVC, c-MWCNT 
and TVC-c-MWCNT). A significant increase in IL-10 
production has been observed in animals treated with 
TVC alone, while IL-6 and IFN-γ have different behav-
iors, being IL-6-induced by DENV serotypes 2 and 3 and 
INF-induced by serotypes 1 and 4, for all groups, includ-
ing the pVAX group. A difference in production of these 
cytokines has not been observed when TVC has been 
administered in conjunction with c-MWCNT (Fig.  6b–
d). The production of IFN-γ and IL-6 is significant for a 
response against a virus, as these are pro-inflammatory 
cytokines that assist in fighting infection. IL-10 produc-
tion is not very favorable to an anti-viral response-frame, 
as this is an anti-inflammatory cytokine that inhibits the 
immune response cells, such as, macrophages and den-
dritic cells, and is seen only in the TVC group. However, 
this can signal the Th2 pattern, once when IL-10 is pro-
duced in conjunction with IL-4 and IL-12 induces Th2 
response.
Perhaps this weak immune response produced by ani-
mals treated with TVC conjugated with c-MWCNT 
could be because of the immunization route chosen, 
which was intramuscular, in contrast to the previous 
studies analysing the effect of CNTs on animals, which 
used intravenous [27, 38–40], intraperitoneal [41, 42], 
and subcutaneous [43] routes, with formation and gen-
eration of a more intense immune response at the site of 
the inoculum. The few studies that used the intramuscu-
lar route for viral immunization with CNTs worked with 
fish and used SWCNTs [44–46].
Conclusions
This study showed that multi-walled carbon nanotubes 
(carboxylated or not) were internalized by Vero cells and 
were found in the cytoplasm and nucleus, associated with 
plasmids. We had to use low concentrations of MWC-
NTs for introduction of exogenous DNA into Vero cells 
and it was not efficient to increase the mRNA compared 
Fig. 4 Western blot. Western blot and densitometry analysis of 
the different treatments. Were evaluated c-MWCNT and MWCNT 
functionalized with TVC, only TVC and TVC with Lipofectamine® 
(TVC-LF) and empty pVAX. Densitometric analysis was performed 
using ImageJ software
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to the TVC transfected with Lipofectamine® 2000 (TVC-
LF), however, it was possible to observe that c-MWCNT 
had a higher expression level than the non-carboxylated 
MWNTC and protein production was higher than both. 
This result suggested a similar behavior that was reported 
for SWCNTs. Carbon nanotubes showed great potential 
for immune response modulation to Th2 pattern with an 
increasing of B cells, interesting behavior for the vaccines 
development with the antibodies production. However, 
other studies could be conducted to enhance the immune 
response, improve Th1 pattern and achieve the same to 
all serotypes, once this study shown a different responses, 
with DENV1 and DENV4 had the same pattern, like as 
DENV2 and DENV3, what suggest a relationship with 
the position of each epitope in the construction, once 
the secondary structure it is one of the antigenicity and 
specificity determinants [47]. Beside preliminary studies 
shown reduction in viral titer to some serotypes DENV1 
and DENV2 (Additional file  1: Figure S1), more studies 
will be done to better immune response, especially to 
improve Th1 pattern and use others cell types to verify 
the influence in the results found in this work.
With regard to the in  vivo use of an intramuscular 
injection, the combination of our vaccine candidate with 
MWCNTs reduced the immune response when com-
pared to TVC. This result discouraged use of the intra-
muscular route, to verify if the MWCNTs were good as 
biological material vehicles for viral immunization in 
mammals. However, it would be interesting to have stud-
ies comparing various routes of inoculation, to confirm 
this result. Therefore, studies conducted with nanoparti-
cles as biological material vehicles should be encouraged.
Fig. 5 Immunophenotyping. Immunophenotyping of lymphocytes of animals subjected to four different treatments (pVAX, TVC, c-MWCNT, TVC-c-
MWCNT). a B cells, b T CD4+ cells, c T CD8+ cells, d CD62L low cells
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Methods
Cell culture
Vero cells (from monkey kidney) were maintained at 
37  °C, in an atmosphere of 5 % CO2, in minimal essen-
tial medium eagle (MEM) supplemented with 10 % fetal 
bovine serum, for promoting growth and 2 % for mainte-
nance of the cell line, in addition to antibiotic solutions: 
penicillin (500 U/mL) and streptomycin (100 µg/mL).
Viral stock
The dengue viruses used in this study were the following 
strains: DENV1 (Nauru Island), DENV2 (New Guinea 
C), DENV3 (H87), and DENV4 (H241), obtained from 
the viral stock of the Molecular Immunovirology Labo-
ratory of the Federal University of Viçosa. Samples from 
each serotype were inoculated into the brains of newborn 
Swiss mice. After the onset of viremia, the brains were 
removed, macerated with 1X PBS (phosphate-buffered 
saline) and subjected to centrifugation at 2500×g for 
10  min. Next, the supernatant was supplemented with 
fetal bovine serum to a final concentration of 20  %, ali-
quoted, and stored in a freezer at −80 °C.
DNA vaccine candidate tetravalent
The TVC used was produced in the Molecular Immuno-
virology Laboratory of the Federal University of Viçosa. 
It was composed of the optimized plasmid vector for 
expression in mammalian cells pVAX1© (Invitrogen Cor-
poration, California—USA), which had inserted genes 
of Domain III of E protein serotypes DENV1, DENV2, 
DENV3 and DENV4, forming a tandem sequence of 
these four gene fragments, generating a polypeptide 
of 60  kDa. This construction was confirmed by PCR, 
restriction, and sequencing assays.
Multi‑walled carbon nanotubes
The MWCNTs used in this study were obtained from 
the Nanomaterials Laboratory of the Physics Depart-
ment of the Federal University of Minas Gerais, granted 
by Professor Luiz Orlando Ladeira. These nanotubes 
Fig. 6 Lymphoproliferation and cytokine production. a Lymphoproliferation of lymphocytes of animals subjected to four different treatments (TVC, 
c-MWCNT, TVC-c-MWCNT) when stimulated with the four serotypes of dengue virus, the medium (negative control), and Concanavalin A (ConA) 
(positive control). b–d Featured cytokine that had a significant increase, showing the levels produced by lymphocytes of animals subjected to four 
different treatments (TVC, c-MWCNT, TVC-c-MWCNT) when stimulated with the four serotypes of the dengue virus and the medium (negative 
control)
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were produced by the chemical vapor deposition process 
from a carbon precursor (ethylene) and a base catalyst 
to nanostructured metal particles (Ni, Fe, Co) having a 
purity level that was in the order of 95 %. The carboxyla-
tion of the nanotubes was made via using a microwave 
in an acidic medium (nitric/sulfuric). It first generated 
defects in the structure and subsequently stabilized these 
defects with the carboxylic groups and, the degree of car-
boxylation was in the order of 10 %.
Synthesis of DNA‑MWCNT
In conjunction with the TVC MWCNT, 20 µg of plasmid 
DNA were placed in PBS solution with carbon nano-
tubes, at a concentration of 10 µg/mL. This solution was 
sonicated for 30 min in an ultrasonic bath, to enable the 
conjugation of DNA to the wall of the MWCNT and this 
was kept on ice until use.
Transmission electron microscopy of DNA‑MWCNT
To characterize the DNA-MWCNT four different sam-
ples of MET were made: pure MWCNT, MWCNT-
DNA, pure c-MWCNT, and DNA-c-MWCNT. After the 
process of sonication for 30 min, the four samples were 
separately placed on and covered with formvar grids for 
1 min and 30 s. Subsequently they were dried and aque-
ous 0.5 % uranyl acetate was added for 15 s and dried, to 
make the contrast of DNA. The samples were left in the 
desiccator for 12 h and visualized in the electron micro-
scope Zeiss transmission EM 109, which belonged to the 
Center for Microscopy and Microanalysis, at the Federal 
University of Viçosa.
Transfection of vero cells
For transfection of cells with pure plasmid DNA (both 
empty plasmids, as TVC), we used the protocol with 
Lipofectamine® 2000 transfection reagent (invitrogen) 
in which 100 µL of MEM medium, without fetal bovine 
serum, was added to the DNA plasmid in a tube. In 
another tube, 1 µL of Lipofectamine® 2000 was added for 
1 µg of DNA in 100 µL of MEM medium. It was left for 
5 min at room temperature. Both tubes were mixed and 
left for 20 min at room temperature. Thereafter, 200 µL 
of this mixture was added to the cells and incubated for 
24 h. For transfection of cells with MWCNT, they were 
used at a concentration of 10  µg/mL and sonicated for 
30 min with and without the plasmid DNA (20 µg) and 
added directly to the cell culture medium and incubated 
for 24 h.
Extraction of total RNA from cells and preparation 
of complementary DNA
After the cells were incubated for 24  h, they were col-
lected and total RNA extraction was done using the RNA 
Isolation PureZOL Reagent (Bio Rad) according to the 
manufacturer’s recommendations. This total RNA was 
used for making the complementary DNA (cDNA) using 
random primers and the reverse transcription reagent 
GoScript Reverse Transcriptase (Promega), following the 
manufacturer’s recommendations.
Western blot
Domain III expression from Vero cells was evalu-
ated, the different cell extracts (pVAX, TVC, MWCNT, 
c-MWCNT and TVC transfected using Lipofectamine® 
2000) precipitated with TCA were applied on polyacryla-
mide gel 10 %, transferred to a nitrocellulose membrane 
using a Semi-dry electrotransfer mini Trans Blot Cell 
(Bio-Rad, California, USA) and transfer buffer (25  mM 
Tris, 190 mM glycine and 20 % methanol). After 1 h trans-
fer membranes were left in blocking solution (PBS, 0.5 % 
Tween 20 and 5  % dried milk) for 16  h under mild stir-
ring. Later, dengue virus polyclonal antibodies (1:3000) 
produced in mice were added to the blocking solution. 
Antibodies were added and left in contact with the mem-
branes for 4 h. The samples were then washed with PBS-
Tween three times for 5  min and secondary antibody 
(1:10,000) anti mouse IgG conjugated to peroxidase was 
added to membrane and left in contact with the mem-
brane for 1  h. After the membranes were washed with 
PBS-Tween three times for 5 min and revelation was per-
formed using DAB (3,3′-diaminobenzidine) is dissolved in 
50 mM Tris–HCl (pH 7.6). Forty microliter of hydrogen 
peroxide were added to each membrane and left for a few 
minutes, and the protein bands appear on the membrane 
the reaction was quenched with distilled water and the 
membranes were allowed to dry and photographed. The 
bands densitometry analysis was performed using ImageJ 
software (https://www.imagej.nih.gov/).
Real‑time polymerase chain reaction
For real-time PCR, specific primers of DENV-2 domain 
III were used at a concentration of 200  nM and 400  ng 
of cDNA transfected cells with four different treatments: 
pVAX, TVC, TVC-MWCNT and TVC-c-MWCNT. We 
used the Eco Real-Time PCR System (Illumina) and the 
data have been analyzed in the EcoStudy software (Illu-
mina). The amplification profile was: 50  °C for 2  min, 
95  °C for 10 min, and 40 cycles at 95  °C for 10 s, 60  °C 
for 30 s, and 95 °C for 15 s. The primers were 5′CCCCTT 
AAGGTGCAGGCTGAGAATGGACA3′, and 5′GGGG 
GTACCTCGCCCAAAATGGCCATTC3′, generating a 
fragment of 417 bp.
Transmission electron microscopy of vero cells
To view the nanotubes within the Vero cells, they 
were incubated with MWCNTs c-MWCNTs at a 
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concentration of 10  mg/mL for 3  h, and subsequently, 
the MEM was removed and trypsin added to release the 
culture flask of cells. The cell suspension was collected, 
centrifuged at 1500×g for 10  min and the supernatant 
was discarded. The cell pellet was washed thrice with PBS 
at 1500×g for 5  min, and after washing, the cells were 
fixed for 2 h in a fixative solution (2.5 % glutaraldehyde, 
0.1 M sodium cacodylate, sucrose 0.2 M). The fixed cells 
were washed with 0.1 M sodium cacodylate for 5 min and 
post-fixed in osmium tetroxide for 30 min. To remove the 
excess osmium, the cells were washed with 0.1 M sodium 
cacodylate for 5 min and then dewatering steps were car-
ried out with solutions of increasing concentrations of 
ethanol (50, 70, 90, 95 and 100 %). Subsequently, the cells 
were infiltrated with LR White resin (Agar Scientific) in 
a ratio of 2:1 (100 % alcohol:resin) for 40 min, then with 
resin LR White (Agar Scientific) in a ratio of 1: 1 (100 % 
alcohol:resin) for 40 min, and finally, infiltrated with pure 
LR White resin for 16 h and left. All these resin infiltra-
tion steps were done in a refrigerator at 4  °C. After this 
time the resin was removed and placed in new neat resin 
sample tubes themselves to the biological material, leav-
ing them in an oven at 65 °C for 48 h to solidify the resin. 
At the end of this time the resin blocks with the biologi-
cal material were removed from the tubing and taken to 
be made into ultramicrotome material sections (100 nm), 
which were collected on grids and then counterstained. 
For this step, the grids were allowed to soak in 1 % ura-
nyl solution for 15  min, washed 50 times in distilled 
water, left in lead citrate solution for 8  min and finally 
washed more than 50 times in distilled water. The grids 
were put under the transmission electron microscope 
to obtain images. This was carried out in the Center for 
Microscopy and Microanalysis at the Federal University 
of Viçosa.
Evaluation of cell viability by a colorimetric test using MTT
In order to assess whether the MWCNTs were toxic to 
Vero cells was done cell cytotoxicity assay with the same, 
which were grown in 96 well plates with an initial num-
ber of 104 cells per well, to reach confluency. Cells were 
grown in MEM medium supplemented with 10  % fetal 
bovine serum at 37  °C in an atmosphere of 5  % CO2. 
After adhesion of the cells, they were removed from 
the medium and added to 100  µL of MWCNT, DNA 
MWCNT c-MWCNT and DNA-c-MWCNT samples, 
diluted in MEM medium, supplemented with 2  % fetal 
bovine serum, at concentrations of 1, 5 10, 25, 50, 100, 
and 200/mL, in nanotubes. Control of this test was done 
with pits which were only added MEM and all the tests 
were done in triplicate. Subsequently, the plates were 
incubated for 24  h, after which time the medium was 
removed and 100 µL of MTT (5 mg/mL) diluted tenfold 
in MEM medium and supplemented with 2 % fetal bovine 
serum was added to the cells in all wells and the plates 
were incubated for 4 h under the same conditions. After 
incubation, the MTT-containing medium was removed 
and 100 µL of isopropanol-HCl solution was added to the 
wells, to solubilize the formazan crystals. The plates were 
shaken gently at room temperature for 20 min for solubi-
lization of the crystals and a reading was done on a spec-
trophotometer with a wavelength of 590 nm.
Immunization of mice
In this study, we used 5-week-old BALB/c female mice. 
They were divided into four groups, with four animals in 
each group, according to the inoculated material in them. 
The groups were: Group 1: pVAX; Group 2: TVC; Group 
3: c-MWCNT; Group 4: TVC-c-MWCNT. For tests with 
these mice, 100 µg of DNA and nanotubes at a concentra-
tion of 10 µg/mL were used, and this step, in vivo studies 
on the c-MWCNTs, was used only once. The non-car-
boxylated CNTs were insoluble and generated a greater 
local inflammatory response. A day prior to the first 
immunization dose of some mice, blood was collected 
by venipuncture in a retro-orbital bag and processed 
to obtain the serum, which was called the pre-immune 
serum. In this procedure, blood samples were left at 
room temperature for 30  min to allow blood clotting, 
then centrifuged at 2500×g for 10  min and the serum 
contained in the supernatant was collected and pooled 
into a single serum pool, which was stored at −20 °C. The 
following day, each mouse from each of the four groups 
was inoculated intramuscularly with the samples belong-
ing to each group. These immunization procedures were 
repeated twice more, with an interval of 15 days between 
them. Furthermore, 14 days after each of the three immu-
nizations, blood from each mouse was collected and 
processed to obtain the serum, just as was done with 
the pre-immune serum, and the serum pools collected 
from each group were stored at −20 °C and subsequently 
tested for the presence of antibodies against different 
serotypes of dengue viruses. The mice were provided by 
the Central Animal Facility of the Federal University of 
Viçosa (UFV) and kept in the vivarium at the Molecular 
Immunovirology Laboratory of UFV. Throughout the 
experimental period the animals had free access to water 
and food and were kept in room temperature, controlled 
ventilation and photoperiod, and the methodology used 
in this project was approved by the Ethics Committee on 
Animal Use of the Federal University of Viçosa. The pro-
cess was named 70/2013.
Immunophenotyping
Spleens from each mouse immunized in the four different 
groups were obtained and macerated in RPMI with 2 % 
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fetal bovine serum (FBS). The tissue extract was trans-
ferred to 15 mL conical tubes and centrifuged at 500×g 
for 5 min at 4 °C. The supernatant was discarded and the 
precipitate was suspended in an erythrocyte lysis buffer, 
left for 5 min at 4 °C and centrifuged again at 500×g for 
5 min at 4  °C. Next, the supernatant was discarded and 
the precipitate was washed with RPMI with 2 % FBS and 
then suspended in the same medium. Cells were counted 
in a Neubauer chamber under an optical microscope 
and a calculation was made to use 1 × 107 cells per well. 
These were seeded into 96 well plates and added in the 
middle of an FACS buffer (1X PBS, FCS 2 %, and 3 mM 
EDTA). The cells were centrifuged at 500×g for 2  min 
in a plate centrifuge and then the supernatant was dis-
carded and the antibody-specific precipitates were added 
to the lymphocyte surface molecules, which are conju-
gated antibodies with fluorophores, for detection by flow 
cytometry (CD3—FITC; CD4—APC Cy 7; CD8—PE 
Cy 7; CD19—PerCP Cy 5.5; CD44—PE; CD62L—PCA). 
They were left in contact with the cells for 30  min at 
4 °C with an FACS buffer, then centrifuged at 500×g for 
2  min and washed with the FACS buffer. The superna-
tant was discarded and the cells were suspended in the 
FACS buffer, to which was added propidium iodide (0.5/
mL). Finally, the cells were taken for analysis in a cytom-
eter, BD FACSVerse Flow Cytometer, from the Center for 
Microscopy and Microanalysis at the Federal University 
of Viçosa.
Lymphoproliferation assay
Spleen cells collected during the methodology described 
in the previous section were counted in a Neubauer 
chamber and a calculation was made to use 1  ×  107 
cells per well. These were seeded in 96-well plates and 
a medium containing sterile PBS 1X, 0.1  % FBS, and 
CFSE dilution of 1: 1000 was added. The cells were left 
in this medium for 10 min at 37  °C, washed thrice with 
RPMI  +  FCS 10  %, centrifuged at 500×g for 5  min at 
4  °C, and then the supernatant was discarded and the 
precipitate was suspended in RPMI medium with 10  % 
FBS. This means that the stimuli that had come from 
brain extracts of infected mice were added to samples 
of each of the four serotypes of dengue viruses (MOI of 
0.1). The negative control cells were only used with the 
medium, and the positive control cells used were stimu-
lated with Concanavalin A (7.5  mg/mL), and all tests 
were done in duplicate. After 3  days of stimulation, the 
cell culture supernatant was collected and stored in a 
freezer at −80 °C for use in the cytokine detection assay. 
The cell precipitate was added to the antibodies to CD4, 
CD8 and CD19 diluted in FACS buffer (1:400) and left in 
contact with them for 30 min at 4 °C. The cells were then 
washed thrice with FACS buffer 500×g for 2 min and sus-
pended in the FACS buffer to which propidium iodide 
(0.5/mL) was added. This was brought in cytometer BD 
FACSVerse Flow Cytometer (BD) of the core for Micros-
copy microanalysis at the Federal University of Viçosa.
Detection of cytokines
For detection of cytokines produced by the cells stimu-
lated lymphoproliferation assay, the supernatant was col-
lected and stored in a freezer at −80  °C, was analyzed 
using the BD CBA Mouse Th1/Th2/Th17 Cytokine Kit 
(BD), according to the recommendations of a manufac-
turer. It is possible to detect the cytokines IL-2, IL-4, IL-6, 
IFN-γ, TNF, IL-17A and IL-10 by using this kit. Samples 
were analyzed in the cytometer BD Flow Cytometer 
FACSVerse (BD) from the Center for Microscopy and 
Microanalysis at the Federal University of Viçosa.
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